| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,151 |
6,180 |
$369K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,327 |
4,539 |
$182K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
8,096 |
6,914 |
$161K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,446 |
2,103 |
$148K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,113 |
1,932 |
$134K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,760 |
1,547 |
$117K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,047 |
1,751 |
$107K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,454 |
1,284 |
$72K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
4,074 |
3,554 |
$58K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,967 |
4,091 |
$58K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,894 |
1,452 |
$48K |
| 92551 |
|
2,821 |
2,520 |
$20K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,035 |
1,657 |
$17K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
417 |
316 |
$11K |
| 87899 |
|
1,320 |
580 |
$11K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
178 |
150 |
$10K |
| 90473 |
|
1,196 |
1,003 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,178 |
411 |
$8K |
| 96161 |
|
1,196 |
955 |
$6K |
| 83655 |
|
919 |
674 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
667 |
532 |
$5K |
| 99173 |
|
3,083 |
2,651 |
$5K |
| 96160 |
|
1,807 |
1,608 |
$3K |
| 87807 |
|
357 |
298 |
$3K |
| 85018 |
|
1,529 |
1,279 |
$2K |
| 96127 |
|
1,809 |
1,255 |
$2K |
| 99051 |
|
162 |
138 |
$2K |
| 81002 |
|
809 |
680 |
$1K |
| 99188 |
|
72 |
51 |
$808.08 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
92 |
88 |
$727.20 |
| 81025 |
|
148 |
112 |
$575.69 |
| 90651 |
|
786 |
645 |
$0.00 |
| 90697 |
|
1,469 |
1,197 |
$0.00 |
| 90680 |
|
1,193 |
1,002 |
$0.00 |
| 90620 |
|
655 |
527 |
$0.00 |
| 90696 |
|
218 |
170 |
$0.00 |
| 90647 |
|
210 |
196 |
$0.00 |
| 90686 |
|
1,586 |
1,361 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
165 |
98 |
$0.00 |
| 90723 |
|
48 |
41 |
$0.00 |
| 90671 |
|
1,027 |
741 |
$0.00 |
| 90710 |
|
1,013 |
856 |
$0.00 |
| 90670 |
|
964 |
874 |
$0.00 |
| 90734 |
|
900 |
729 |
$0.00 |
| 90633 |
|
1,238 |
1,032 |
$0.00 |
| 90715 |
|
298 |
250 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
165 |
98 |
$0.00 |
| 90700 |
|
366 |
296 |
$0.00 |
| 80061 |
Lipid panel |
82 |
41 |
$0.00 |